CrushSCI.com
51.4Average days
34Median days
3Fastest days
236Longest days
3842025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

10 days

Heritability of Transcranial Doppler Velocity in Sickle Cell Anemia Across Two Independent Pediatric Cohorts

Authors
Guolian Kang; Clifford M. Takemoto; Mitchell J. Weiss; Parul Rai; Deepa Manwani; Sara R. Rashkin; Chengzhou Wu; Michael R. DeBaunShow moreShow less
Affiliations
1. Department of Biostatistics St. Jude Children's Research Hospital Memphis Tennessee USA; 2. Department of Hematology St. Jude Children's Research Hospital Memphis Tennessee USA; 3. Department of Pediatrics Vanderbilt University Medical School Nashville Tennessee USAShow moreShow less
Source PDF DOI Publisher page
6 days

Longevity in Thalassemia: Which Clock Are We Trying to Slow?

Authors
Khaled M. Musallam; Shahrukh Hashmi; Mohamed Al Ameri; Ayman W. El‐Hattab; Ali T. TaherShow moreShow less
Affiliations
1. Center for Research on Rare Blood Disorders (CR‐RBD) and Thalassemia & Sickle Cell Center Burjeel Cancer Institute, Burjeel Medical City Abu Dhabi UAE; 2. Department of Public Health & Epidemiology College of Medicine and Health Sciences, Khalifa University Abu Dhabi UAE; 3. Division of Hematology/Oncology, Department of Pediatrics Weill Cornell Medicine New York New York USA; 4. Department of Health, Health Life Sciences Abu Dhabi UAE; 5. Department of Biology and Life Sciences Mohamed Bin Zayed University of Artificial Intelligence Abu Dhabi UAE; 6. Department of Biomedical Sciences College of Medicine and Health Sciences, Khalifa University Abu Dhabi UAE; 7. Genetics and Rare Disease Center, Burjeel Cancer Institute, Burjeel Medical City Abu Dhabi UAE; 8. Department of Medical Sciences College of Medicine and Health Sciences, Khalifa University Abu Dhabi UAE; 9. Department of Internal Medicine American University of Beirut Medical Center Beirut LebanonShow moreShow less
Source PDF DOI Publisher page
83 days

Outcomes of Patients With AL Amyloidosis and End‐Stage Renal Disease After Initiation of Therapy

Authors
Foteini Theodorakakou; Lilli Sophie Sester; Ute Hegenbart; Paolo Milani; Claudia Bellofiore; Erasmia Psimenou; Charikleia Gakiopoulou; Meletios A. Dimopoulos; Giovanni Palladini; Stefan O. Schönland; Efstathios KastritisShow moreShow less
Affiliations
1. Department of Clinical Therapeutics National and Kapodistrian University of Athens, School of Medicine Athens Greece; 2. Department of Internal Medicine V, Hematology, Oncology and Rheumatology, Amyloidosis Center University Hospital Heidelberg Heidelberg Germany; 3. Department of Molecular Medicine University of Pavia Pavia Italy; 4. Amyloidosis Research and Treatment Center Fondazione IRCCS Policlinico San Matteo Pavia Italy; 5. First Department of Pathology National and Kapodistrian University of Athens Athens Greece; 6. Department of Medicine Korea University Seoul South KoreaShow moreShow less
Source PDF DOI Publisher page
8 days

Voxelotor in Children With Conditional Cerebral Blood Flow Velocity: What HOPE Kids 2 Teaches Us About Efficacy, Mortality, and Malaria Risk in Africa

Authors
Jeffrey G. Edwards; Julie Makani; Natasha M. ArcherShow moreShow less
Affiliations
1. Department of Global Pediatric Medicine St. Jude Children's Research Hospital Memphis Tennessee USA; 2. Muhimbili University of Health and Allied Sciences Dar es Salaam Tanzania; 3. Boston Children's Hospital Dana‐Farber Cancer Institute Boston Massachusetts USAShow moreShow less
Source PDF DOI Publisher page
5 days

Current Treatment Landscape and Advances in Lymphoma in China: A Special Issue

Authors
Yuqin SongShow moreShow less
Affiliations
1. Department of Lymphoma Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute Beijing ChinaShow moreShow less
Source PDF DOI Publisher page
154 days

Development and Validation of a Novel Geriatric Risk Score for Prognostication in Older Patients With Hodgkin Lymphoma: A Multicenter Retrospective Study

Authors
Peiqi Zhao; Yihan Wang; Min Bai; Chen Huang; Jiesong Wang; Yajun Li; Yanan Jiang; Ganggang Wang; Feng Zhu; Shu Zhao; Wei Guo; Shukai Qiao; Jianxia He; Ji Ma; Yanyan Zhang; Lei Zhu; Li Li; Wenyue Yu; Shaozhen Chen; Junqing Xu; Ou Bai; Hui Zhou; Qingyuan Zhang; Liping Su; Yuanlin Xu; Huilai ZhangShow moreShow less
Affiliations
1. Department of Lymphoma Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin Medical University Tianjin China; 2. Department of Internal Medicine Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou China; 3. Department of Hematology Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University Taiyuan China; 4. Department of Hematology The Fourth Hospital of Hebei Medical University Shijiazhuang China; 5. Department of Lymphoma & Head and Neck Oncology, College of Clinical Medicine for Oncology Fujian Medical University Fuzhou China; 6. Department of Lymphoma and Hematology The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital Changsha China; 7. Department of Hematology Yantai Yuhuangding Hospital Affiliated to Qingdao University Yantai China; 8. Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital Taiyuan China; 9. Department of Hematology The Affiliated Hospital of Xuzhou Medical University Xuzhou China; 10. Department of Medical Oncology Harbin Medical University Cancer Hospital, Harbin Medical University Harbin China; 11. Department of Hematology The First Hospital of Jilin University Changchun China; 12. Department of Hematology The Second Hospital of Hebei Medical University Shijiazhuang China; 13. Department of Hematology Shanxi Provincial People's Hospital Taiyuan China; 14. Department of Hematology, Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan China; 15. Nanjing Geneseeq Technology Inc. Nanjing China; 16. Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital Tianjin Medical University Tianjin China; 17. Clinical Pathology Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital Taiyuan China; 18. Cancer Research Center, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei ChinaShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.